Shanghai MicroPort Electrophysiology Medical Technology Co., Ltd. (688351) disclosed its third quarter report on October 22, 2024, and the company achieved operating income of 291 million yuan in the first three quarters of 2024, a year-on-year increase of 23.21%; the net profit attributable to shareholders of the listed company was 42 million yuan, a year-on-year increase of 262.22%; the net profit attributable to the parent company after deducting non-profits was -752,500 yuan, a year-on-year increase of 95.69%; The basic earnings per share was 0.09 yuan, a year-on-year increase of 262.04%;
Based on the closing price on October 21, 2024, Microelectrophysiology currently has a price-to-earnings ratio of about 441.84x, a price-to-book ratio of about 5.32x, and a price-to-sales ratio of about 27.58x.
| operating income at the end of the date | (10,000 yuan). | Revenue year-on-year (%) | Net profit (10,000 yuan), | net profit year-on-year (%) | , net profit attributable to the parent company after deducting non-recurring gains and losses (10,000 yuan), | netprofit attributable to the parent company (%) year-on-year (%) | , earningsper share (yuan/share), |
| the third quarter of 2022 | 19190.78 | 39.71 | 270.82 | 149.22-60.58-0.01||||
| Q3 2023 | 23607.14 | 23.01 | 1151.96 | 325.36-1745.32-2781.010.02 | |||
| Q3 2024 | 29086.61 | 23.21 | 4172.67 | 262.22 | -75.25 | 95.69 | 0.09 |







Ticker Name
Percentage Change
Inclusion Date